跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
普托平 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lansoprazole Orally Disintegrating Tablets
Approved
化学药品
Lansoprazole Orally Disintegrating Tablets
TEVA TAKEDA YAKUHIN LTD.
🇨🇳 National Medical Products Administration
Approval Date
Apr 16, 2020
Approval ID
7MazXcRivly
Company
TEVA TAKEDA YAKUHIN LTD.
Type
化学药品
Approval Details
Approval Id
7MazXcRivly
Approval Number
H20120212
Generic Name
兰索拉唑口崩片
Generic Name En
Lansoprazole Orally Disintegrating Tablets
Trade Name
普托平
Brand Name
普托平
Drug Type
化学药品
Dosage Form
片剂
Strength
30mg
Reg Date
2020-04-16
Expired Date
2023-11-01
Company Name
TEVA TAKEDA YAKUHIN LTD.
Company Address
1-24-11,Taiko, Nakamura-ku,Nagoya-shi,Aichi,JAPAN
Production Company Name
kokando co.ltd. headquarters'plant
Production Company Address
2-9-1,Umezawacho, Toyama City, Toyama, Japan
Company Detail Path
/organization/teva-takeda-yakuhin-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 16, 2020
Approval ID
7MazXcRivly
Type
化学药品
Back to NMPA Approvals
